Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

Item
http://www.wikidata.org/entity/Q33694866
Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerHigh expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.Application of an electrochemical immunosensor with a MWCNT/PDAA modified electrode for detection of serum trypsin.CBX7 modulates the expression of genes critical for cancer progressionEffects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis.Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer.The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development.MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E-cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway.Cbl-b accelerates trypsin-induced cell detachment through ubiquitination and degradation of proline-rich tyrosine kinase 2.
P2860

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

Item
http://www.wikidata.org/entity/Q33694866
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Increased serum levels of tumo ...... in colorectal cancer patients
@ast
Increased serum levels of tumo ...... in colorectal cancer patients
@en
type
label
Increased serum levels of tumo ...... in colorectal cancer patients
@ast
Increased serum levels of tumo ...... in colorectal cancer patients
@en
prefLabel
Increased serum levels of tumo ...... in colorectal cancer patients
@ast
Increased serum levels of tumo ...... in colorectal cancer patients
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Increased serum levels of tumo ...... in colorectal cancer patients
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P921
P932